Loading…
Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients
To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis. Retrospective observational case series. Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed....
Saved in:
Published in: | American journal of ophthalmology 2018-12, Vol.196, p.18-25 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183 |
---|---|
cites | cdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183 |
container_end_page | 25 |
container_issue | |
container_start_page | 18 |
container_title | American journal of ophthalmology |
container_volume | 196 |
creator | Williams, Basil K. Di Nicola, Maura Ferenczy, Sandor Shields, Jerry A. Shields, Carol L. |
description | To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis.
Retrospective observational case series.
Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies.
Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%).
Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes. |
doi_str_mv | 10.1016/j.ajo.2018.08.011 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2089855240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939418304537</els_id><sourcerecordid>2089855240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVpabZJf0AvRcce4q1G65Wl9hSWbhNISQ7pWcjSONFiW1tJDuRP5DdXZrchp8LAMPC9B_MeIZ-ALYGB-Lpbml1YcgZyycoAvCELkI2qQCp4SxaMMV6plapPyIeUduUUTd28JyerwkohmwV5voo-0V_exvCAgxnvfRhMDsmnb3TT-9Fb05_TbT-FiMmiH-nFzNxHs394OqdmdPRmn2eKbopDxNEivQvDkXhN0y2aPBUbWlygLvyY0E7ZPyK9NdnjmNMZedeZPuHH4z4lv7c_7jaX1fXNz6vNxXVla1C5AuVqYKYWrVQoBF9Z1XBwTSNdy2tRtkDXApOdaKFjUnFuXYO2426tOMjVKfly8N3H8GfClPXgy3t9b0YMU9K8aOR6zWtWUDigJaKUInZ6H_1g4pMGpuca9E6XGvRcg2ZlAIrm89F-agd0L4p_uRfg-wHA8uSjx6iT9XN2zke0Wbvg_2P_FzRYmcc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2089855240</pqid></control><display><type>article</type><title>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</title><source>Elsevier</source><creator>Williams, Basil K. ; Di Nicola, Maura ; Ferenczy, Sandor ; Shields, Jerry A. ; Shields, Carol L.</creator><creatorcontrib>Williams, Basil K. ; Di Nicola, Maura ; Ferenczy, Sandor ; Shields, Jerry A. ; Shields, Carol L.</creatorcontrib><description>To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis.
Retrospective observational case series.
Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies.
Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%).
Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/j.ajo.2018.08.011</identifier><identifier>PMID: 30118687</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Female ; Fluorescein Angiography - methods ; Hemangioma - pathology ; Humans ; Iris - blood supply ; Iris Diseases - diagnostic imaging ; Iris Diseases - pathology ; Male ; Microvessels - pathology ; Middle Aged ; Retrospective Studies ; Tomography, Optical Coherence - methods ; Visual Acuity</subject><ispartof>American journal of ophthalmology, 2018-12, Vol.196, p.18-25</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</citedby><cites>FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</cites><orcidid>0000-0002-6209-4191 ; 0000-0002-3288-3632 ; 0000-0002-7257-026X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30118687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, Basil K.</creatorcontrib><creatorcontrib>Di Nicola, Maura</creatorcontrib><creatorcontrib>Ferenczy, Sandor</creatorcontrib><creatorcontrib>Shields, Jerry A.</creatorcontrib><creatorcontrib>Shields, Carol L.</creatorcontrib><title>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis.
Retrospective observational case series.
Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies.
Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%).
Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Fluorescein Angiography - methods</subject><subject>Hemangioma - pathology</subject><subject>Humans</subject><subject>Iris - blood supply</subject><subject>Iris Diseases - diagnostic imaging</subject><subject>Iris Diseases - pathology</subject><subject>Male</subject><subject>Microvessels - pathology</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Tomography, Optical Coherence - methods</subject><subject>Visual Acuity</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kUFr3DAQhUVpabZJf0AvRcce4q1G65Wl9hSWbhNISQ7pWcjSONFiW1tJDuRP5DdXZrchp8LAMPC9B_MeIZ-ALYGB-Lpbml1YcgZyycoAvCELkI2qQCp4SxaMMV6plapPyIeUduUUTd28JyerwkohmwV5voo-0V_exvCAgxnvfRhMDsmnb3TT-9Fb05_TbT-FiMmiH-nFzNxHs394OqdmdPRmn2eKbopDxNEivQvDkXhN0y2aPBUbWlygLvyY0E7ZPyK9NdnjmNMZedeZPuHH4z4lv7c_7jaX1fXNz6vNxXVla1C5AuVqYKYWrVQoBF9Z1XBwTSNdy2tRtkDXApOdaKFjUnFuXYO2426tOMjVKfly8N3H8GfClPXgy3t9b0YMU9K8aOR6zWtWUDigJaKUInZ6H_1g4pMGpuca9E6XGvRcg2ZlAIrm89F-agd0L4p_uRfg-wHA8uSjx6iT9XN2zke0Wbvg_2P_FzRYmcc</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Williams, Basil K.</creator><creator>Di Nicola, Maura</creator><creator>Ferenczy, Sandor</creator><creator>Shields, Jerry A.</creator><creator>Shields, Carol L.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6209-4191</orcidid><orcidid>https://orcid.org/0000-0002-3288-3632</orcidid><orcidid>https://orcid.org/0000-0002-7257-026X</orcidid></search><sort><creationdate>201812</creationdate><title>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</title><author>Williams, Basil K. ; Di Nicola, Maura ; Ferenczy, Sandor ; Shields, Jerry A. ; Shields, Carol L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Fluorescein Angiography - methods</topic><topic>Hemangioma - pathology</topic><topic>Humans</topic><topic>Iris - blood supply</topic><topic>Iris Diseases - diagnostic imaging</topic><topic>Iris Diseases - pathology</topic><topic>Male</topic><topic>Microvessels - pathology</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Tomography, Optical Coherence - methods</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, Basil K.</creatorcontrib><creatorcontrib>Di Nicola, Maura</creatorcontrib><creatorcontrib>Ferenczy, Sandor</creatorcontrib><creatorcontrib>Shields, Jerry A.</creatorcontrib><creatorcontrib>Shields, Carol L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, Basil K.</au><au>Di Nicola, Maura</au><au>Ferenczy, Sandor</au><au>Shields, Jerry A.</au><au>Shields, Carol L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>2018-12</date><risdate>2018</risdate><volume>196</volume><spage>18</spage><epage>25</epage><pages>18-25</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><abstract>To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis.
Retrospective observational case series.
Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies.
Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%).
Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30118687</pmid><doi>10.1016/j.ajo.2018.08.011</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6209-4191</orcidid><orcidid>https://orcid.org/0000-0002-3288-3632</orcidid><orcidid>https://orcid.org/0000-0002-7257-026X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9394 |
ispartof | American journal of ophthalmology, 2018-12, Vol.196, p.18-25 |
issn | 0002-9394 1879-1891 |
language | eng |
recordid | cdi_proquest_miscellaneous_2089855240 |
source | Elsevier |
subjects | Aged Aged, 80 and over Female Fluorescein Angiography - methods Hemangioma - pathology Humans Iris - blood supply Iris Diseases - diagnostic imaging Iris Diseases - pathology Male Microvessels - pathology Middle Aged Retrospective Studies Tomography, Optical Coherence - methods Visual Acuity |
title | Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A14%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Iris%20Microhemangiomatosis:%20Clinical,%20Fluorescein%20Angiography,%20and%20Optical%20Coherence%20Tomography%20Angiography%20Features%20in%2014%20Consecutive%20Patients&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=Williams,%20Basil%20K.&rft.date=2018-12&rft.volume=196&rft.spage=18&rft.epage=25&rft.pages=18-25&rft.issn=0002-9394&rft.eissn=1879-1891&rft_id=info:doi/10.1016/j.ajo.2018.08.011&rft_dat=%3Cproquest_cross%3E2089855240%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2089855240&rft_id=info:pmid/30118687&rfr_iscdi=true |